Clinical Trial Update: Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial investigating ex vivo expanded NK cell infusion to reduce relapse after hematopoietic stem cell transplantation in hematologic malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• Ex vivo expanded NK cells infusion

Snippet

Sponsor: Sichuan University | Conditions: Hematologic Malignancy | Phase 1, Phase 2 | Status: UNKNOWN